First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
| dc.contributor.author | Chabala, Chishala | |
| dc.contributor.author | Jacobs, Tom G. | |
| dc.contributor.author | Moraleda, Cinta | |
| dc.contributor.author | Ndaferankhande, John M. | |
| dc.contributor.author | Mumbiro, Vivian | |
| dc.contributor.author | Passanduca, Alfeu | |
| dc.contributor.author | Namuziya, Natasha | |
| dc.contributor.author | Tagarro García, Alfredo | |
| dc.contributor.author | Aarnoutse, Rob E. | |
| dc.contributor.author | EMPIRICAL Clinical Trial Group | |
| dc.contributor.author | Et al. | |
| dc.date.accessioned | 2023-11-27T18:11:19Z | |
| dc.date.available | 2023-11-27T18:11:19Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants. | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 2.5 Q1 JCR 2023 | spa |
| dc.description.impact | 0.918 Q1 SJR 2023 | spa |
| dc.description.impact | No data IDR 2023 | spa |
| dc.identifier.citation | Chabala, C., Jacobs, T. G., Moraleda, C., Ndaferankhande, J. M., Mumbiro, V., Passanduca, A., Namuziya, N., Nalwanga, D., Musiime, V., Ballesteros, A., Domínguez-Rodríguez, S., Chitsamatanga, M., Cassia, U., Nduna, B., Bramugy, J., Sacarlal, J., Madrid, L., Nathoo, K. J., Colbers, A., … Manukyan, L. (2023). First-line antituberculosis drug concentrations in infants with hiv and a history of recent admission with severe pneumonia. Journal of the Pediatric Infectious Diseases Society, 12(11), 581-585. https://doi.org/10.1093/jpids/piad088 | spa |
| dc.identifier.doi | 10.1093/jpids/piad088 | |
| dc.identifier.issn | 2048-7193 | |
| dc.identifier.issn | 2048-7207 | |
| dc.identifier.uri | http://hdl.handle.net/11268/12395 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.relation.projectID | EDCTP2 (European Union RIA2017MC-2013) | spa |
| dc.relation.publisherversion | https://doi.org/10.1093/jpids/piad088 | spa |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.accessRights | open access | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject.other | Síndrome de inmunodeficiencia adquirida | spa |
| dc.subject.other | Síndrome respiratorio agudo grave | spa |
| dc.subject.other | Antituberculosos | spa |
| dc.subject.unesco | Aparato respiratorio | spa |
| dc.subject.unesco | Enfermedad transmisible | spa |
| dc.subject.unesco | Pediatría | spa |
| dc.title | First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | f0bf0892-c73b-4af1-bbfe-edcb3e5c17b2 | |
| relation.isAuthorOfPublication.latestForDiscovery | f0bf0892-c73b-4af1-bbfe-edcb3e5c17b2 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Tagarro_JPIDS_2023.pdf
- Size:
- 285.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Versión del editor

